HS

Haruo Sugiyama

II International Institute Of Cancer Immunology: 52 patents #1 of 27Top 4%
OU Osaka University: 8 patents #54 of 1,984Top 3%
ND Nitto Denko: 5 patents #655 of 2,479Top 30%
CP Chugai Pharmaceutical: 4 patents #251 of 1,238Top 25%
DC Dainippon Sumitomo Pharma Co.: 4 patents #12 of 256Top 5%
UN Unknown: 4 patents #4,220 of 83,584Top 6%
OC Otsuka Pharmaceutical Co.: 2 patents #437 of 1,273Top 35%
TK Tadamitsu Kishimoto: 2 patents #3 of 20Top 15%
NC Nippon Light Metal Company: 2 patents #109 of 499Top 25%
KC Knc Laboratories Co.: 1 patents #9 of 38Top 25%
KT Kabushiki Kaisha Toshiba: 1 patents #13,537 of 21,451Top 65%
📍 Ikeda, JP: #2 of 425 inventorsTop 1%
Overall (All Time): #26,269 of 4,157,543Top 1%
74
Patents All Time

Issued Patents All Time

Showing 26–50 of 74 patents

Patent #TitleCo-InventorsDate
10195258 Tape preparation of WT1 peptide cancer vaccine for transdermal administration Yoshiki Maeda, Katsuyuki Okubo, Daisuke ASARI, Arimichi OKAZAKI, Takuya SHISHIDO +1 more 2019-02-05
10139395 Method for activation of helper T cell and composition for use in the method 2018-11-27
10124046 HLA-DR-binding antigen peptide derived from WT1 2018-11-13
10093977 Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene, and use of them 2018-10-09
10076491 Vaccine composition Daisuke ASARI, Katsuyuki Okubo, Takuya SHISHIDO, Arimichi OKAZAKI, Yoshiki Maeda +3 more 2018-09-18
10071051 WT1 peptide cancer vaccine composition for transdermal administration Katsuyuki Okubo, Yoshiki Maeda, Arimichi OKAZAKI, Daisuke ASARI, Takuya SHISHIDO +1 more 2018-09-11
9851356 Method for measuring anti-WT1 antibody Yusuke Oji, Kiyonori Katsuragi, Hideaki Tanaka, Shinji Sogo, Yoshihiro Goto +2 more 2017-12-26
9833493 Method for activating helper T cell Hiroshi Kubo, Shinji Sogo 2017-12-05
9803246 Receptor gene for peptide cancer antigen-specific T cell 2017-10-31
9539299 Combination therapy with WT1 peptide vaccine and temozolomide Toshiki Yoshimine, Akihiro Tsuboi, Naoya Hashimoto 2017-01-10
9403886 Tumor antigen based on products of the tumor suppressor gene WT1 Yoshihiro Oka 2016-08-02
9272026 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same 2016-03-01
9266932 Cancer antigen helper peptide 2016-02-23
9119801 Cancer vaccine composition 2015-09-01
9097717 Methods of killing myeloma stem and precursor cells by administering anti-CD48 antibodies Naoki Hosen 2015-08-04
9086415 Method for examining WT1-related disease 2015-07-21
8968745 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same 2015-03-03
8945578 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same 2015-02-03
8933038 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same 2015-01-13
8778350 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same 2014-07-15
8759483 HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same 2014-06-24
8735357 Method of inducing antigen-specific T cells 2014-05-27
8653038 HLA-A* 1101-restricted WT1 peptide and pharmaceutical composition comprising the same 2014-02-18
8603997 siRNA that inhibits WT1 gene expression and uses thereof Yusuke Oji 2013-12-10
8557779 Cancer vaccine composition 2013-10-15